History and Technology, Volume 29, Issue 2 (2013)

Browse this journal
Sample our Humanities journals, sign in here to start your FREE access for 14 days

History and Technology, Volume 29, Issue 2 (2013)

See all volumes and issues
Vol 39, 2023 Vol 38, 2022 Vol 37, 2021 Vol 36, 2020 Vol 35, 2019 Vol 34, 2018 Vol 33, 2017 Vol 32, 2016 Vol 31, 2015 Vol 30, 2014 Volume 29, 2013 Vol 28, 2012 Vol 27, 2011 Vol 26, 2010 Vol 25, 2009 Vol 24, 2008 Vol 23, 2007 Vol 22, 2006 Vol 21, 2005 Vol 20, 2004 Vol 19, 2003 Vol 18, 2002 Vol 17, 2000-2001 Vol 16, 1999-2000 Vol 15, 1998-1999 Vol 14, 1997-1998 Vol 13, 1996-1997 Vol 12, 1994-1995 Vol 11, 1994 Vol 10, 1993 Vol 9, 1992 Vol 8, 1991-1992 Vol 7, 1990-1991 Vol 6, 1988 Vol 5, 1988 Vol 4, 1987 Vol 3, 1986-1987 Vol 2, 1985-1986 Vol 1, 1983-1984
Download citations Download PDFs Download issue

Pharmaceutical firms and the construction of drug markets: From branding to scientific marketing

Introduction

Introduction
Pharmaceutical firms and the construction of drug markets: from branding to scientific marketing
Jean-Paul Gaudillière & Ulrike Thoms
Pages: 105-115
Published online: 12 Nov 2013
First Page PreviewforPharmaceutical firms and the construction of drug markets: from branding to scientific marketing | Full Text | References | PDF (102.3 KB)
  • 2507 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access

Articles

Article
A different mode of marketing? The importance of scientific articles in the marketing process of Salvarsan
Axel C. Hüntelmann
Pages: 116-134
Published online: 12 Nov 2013
AbstractforA different mode of marketing? The importance of scientific articles in the marketing process of Salvarsan | Full Text | References | PDF (582.2 KB)
  • 243 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
‘The Strophanthin question’: early scientific marketing of cardiac drugs in two national markets (France and Germany, 1900–1930)
Christian Bonah
Pages: 135-152
Published online: 08 Oct 2013
Abstractfor‘The Strophanthin question’: early scientific marketing of cardiac drugs in two national markets (France and Germany, 1900–1930) | Full Text | References | PDF (432.1 KB)
  • 164 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
‘Doriden von Ciba’: sleeping pills, pharmaceutical marketing, and Thalidomide, 1955–1963
Nils Kessel
Pages: 153-168
Published online: 12 Nov 2013
Abstractfor‘Doriden von Ciba’: sleeping pills, pharmaceutical marketing, and Thalidomide, 1955–1963 | Full Text | References | PDF (302.8 KB)
  • 666 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Standardizing selling. Pharmaceutical marketing, the pharmaceutical company and the marketing expert (1900–1980)
Ulrike Thoms
Pages: 169-187
Published online: 12 Nov 2013
AbstractforStandardizing selling. Pharmaceutical marketing, the pharmaceutical company and the marketing expert (1900–1980) | Full Text | References | PDF (141.9 KB)
  • 507 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
From Propaganda to scientific marketing: Schering, cortisone, and the construction of drug markets
Jean-Paul Gaudillière
Pages: 188-209
Published online: 12 Nov 2013
AbstractforFrom Propaganda to scientific marketing: Schering, cortisone, and the construction of drug markets | Full Text | References | PDF (293.6 KB)
  • 305 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
The materiality of the brand: Form, function, and the pharmaceutical trademark
Jeremy A. Greene
Pages: 210-226
Published online: 09 Sep 2013
AbstractforThe materiality of the brand: Form, function, and the pharmaceutical trademark | Full Text | References | PDF (383 KB)
  • 612 Views
  • 4 CrossRef citations
  • 0Altmetric

Explore articles